The QualityStocks Daily Newsletter for Thursday, April 15th, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Stock Market News Alert (SSWC)


CRWE Wall Street (SRS)


OTC Picks (SNRS)

The QualityStocks Daily

Yayi International Inc. (YYIN)

China Vesting reported last week on Yayi International Inc. (YYIN), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Yayi International Inc. is the first mover and the leading producer and distributor of premium goat-milk formula products. These are for infants, toddlers, young children and adults throughout the People's Republic of China. The Company operates through their subsidiaries: Tianjin Yayi Industrial Co., Limited, Weinan Milkgoat Production Co., Ltd. and Fuping Milkgoat Dairy Co., Ltd. Yayi International has their headquarters in Tianjin, China.

Yayi targets their current formula product lines at the premium market segment and health-conscious consumers. The Company has a vertically integrated production process. They source raw goat milk from their proprietary dairy farms and neighboring goat dairy farmers on a long-term contract basis in milk collection centers. These centers ensure high quality control of their products.

Their distribution network consists of a nationwide footprint across China in 27 provinces and municipalities. These include infant-maternity store chains, supermarkets (including multinational chains), and drug stores as well as catalogue sales and a dedicated online store at Taobao.com.

This past November, Yayi announced that they began work on a new deep-processing facility in Shaanxi Province. The new facility is to become the largest goat milk production-base in China. Once in production at the end of 2010, the new facility will increase the Company's existing production capacity in Shaanxi Province by 400 percent. The new plant is in Weinan, Shaanxi Province in northwestern China. This region is where dairy goats are abundant and of optimal breed for milk production.

Yesterday, Yayi International Inc. announced that they have provided new guidance for the fiscal year ending March 31, 2011. This is because of stronger than expected growth opportunities. The Company now expects net sales for the new fiscal year ending March 31, 2011 to be in the range of $58.6 million to $65.9 million. This is compared with the Company's earlier guidance of net sales between $43.9 million and $58.6 million for the fiscal year ending October 31, 2010.
"We are proud to ramp up sales in a very short time span supported by the commitment of our distributors," said Ms. Li Liu, Chief Executive Officer of Yayi International. "This progress demonstrates the strong brand equity commanded by our 'Milk Goat' brand and the premium quality of our goat milk products. Our diligent efforts for the past few months to restructure our sales network and refine marketing strategy have finally translated into a solid pipeline of sales contracts, indicating significant sales growth going forward."

Yayi International Inc. (YYIN) closed Thursday's trading at $2.95 up 4.61 percent. Volume was 11,000.

Southwest Bancorp Inc. (OKSB)

The Street reported earlier on Southwest Bancorp Inc. (OKSB), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Southwest Bancorp Inc. is the financial holding company for Stillwater National Bank and Trust Company, Bank of Kansas, SNB Capital Corporation, Healthcare Strategic Support, Inc., and Business Consulting Group, Inc. Trading on the NASDAQ Global Select Market, the Company, through their subsidiaries, offers commercial and consumer lending, deposit, and investment services, and specialized cash management, consulting, and other financial services. They do this from offices in Oklahoma, Texas, and Kansas, and on the Internet, through SNB DirectBanker®. Southwest Bancorp Inc. has their headquarters in Stillwater, Oklahoma.

The Company organized in 1981, and as of recent report had assets of $3.1 billion. The Company's corporate vision includes a commercial banking model and a community-banking model focusing on a more traditional banking operation in their three-state market.

Southwest Bancorp Inc. operates seven offices in Texas, eleven offices in Oklahoma, and nine offices in Kansas. At December 31, 2009, the Company's Texas segment accounted for $1.1 billion, or 40 percent of total portfolio loans. Next was $933.2 million, or 36 percent, from their Oklahoma segment, and $359.6 million, or 14 percent, from their Kansas segment. In addition, there was $277.5 million, or 11 percent, from their other states segment.

Stillwater National Bank & Trust Company (SNB), chartered in 1894, offers commercial and deposit services from offices in Stillwater, Tulsa, Oklahoma City, Edmond, and Chickasha, Oklahoma. In Texas, SNB has branding as SNB Bank of Austin, SNB Bank of Dallas, SNB Bank of San Antonio and SNB Bank of Houston.

Bank of Kansas started offering financial services in 1907. In late July 2007, Southwest Bancorp, Inc. purchased and received approval for the state bank charter for Bank of Kansas. On June 19, 2009, the bank acquired the First National Bank of Anthony, Kansas in an FDIC-assisted transaction. The bank now has full service branches in Hutchinson, South Hutchinson, Anthony, Harper, Mayfield, West Wichita, East Wichita and Overland Park, Kansas.

Southwest Bancorp Inc. (OKSB) closed Thursday's trading session at $12.08 up 3.25 percent. Volume was 136,473.

SciClone Pharmaceuticals, Inc. (SCLN)

This week, Greenbackers reported on SciClone Pharmaceuticals, Inc. (SCLN), Wall Street Resources, Penny Invest, and StockEgg.com did earlier, and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company has a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. SciClone Pharmaceuticals, Inc. has their headquarters in Foster City, California. They trade on the NASDAQ Global Market.

The Company's ZADAXIN® (thymalfasin or thymosin alpha 1) sells in more than 30 countries. It sells as a treatment for hepatitis B (HBV) and hepatitis C (HCV), certain cancers and as a vaccine adjuvant. ZADAXIN® has approval in Italy and 12 other countries as an adjuvant for influenza vaccine in immunocompromised patients or as an immune stimulant.

SciClone Pharmaceuticals continues to see commercial opportunity, mainly in Italy, in the potential of ZADAXIN to enhance the immune response to H1N1 pandemic flu vaccines.  The Company reported initial results in early 2010 from a clinical study examining ZADAXIN's ability to enhance response to the H1N1 vaccine.

SciClone Pharmaceuticals, Inc.'s development pipeline of drug candidates includes thymalfasin, which is in clinical studies as an enhancer of vaccines. Their pipeline also includes thymalfasin, for stage IV melanoma. For this, the Company has reached agreement with the FDA on the design of a phase 3 trial.

Their SCV-07 is in clinical studies for the delay to onset of severe oral mucositis (OM) in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck.  SCV-07 is also in a phase 2 trial for the treatment of HCV. The Company has exclusive commercialization and distribution rights to DC Bead™ in China. There, the product is under regulatory review.

SciClone Pharmaceuticals, Inc. also has exclusive commercialization and distribution rights to the anti-nausea drug ondansetron RapidFilm™ in China and Vietnam. The Company will seek regulatory approval for this drug.

On March 30, 2010, SciClone Pharmaceuticals, Inc. announced topline results from their phase 2 clinical trial of SCV-07 for the prevention of severe oral mucositis (OM).  OM is a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.

Patients receiving the higher dose (0.1 mg/kg) of SCV-07 showed a trend towards delay to onset of severe OM, the study's primary endpoint. Patients in the low dose treatment arm (0.02 mg/kg) appeared to do worse than placebo. This suggests that the treatment effect is sensitive to dose. SCV-07 was safe and well tolerated with no drug-related serious adverse events reported. This indicates that there is potential to administer higher doses of SCV-07 in future clinical studies.

The Company intends to initiate discussions with the United States Food and Drug Administration (FDA). This is in regards to the design of a second phase 2 study of SCV-07 for the prevention of OM, which would involve higher doses. They also submitted a late-breaking abstract on results of this study for the 2010 American Society of Clinical Oncology Annual Meeting.

SciClone Pharmaceuticals, Inc. (SCLN) closed today's session at $4.40 up 1.85 percent. Volume was 538,175.

Uranium International Corp. (URNI)

We are highlighting Uranium International Corp. (URNI) today, here at the QualityStocks Daily Newsletter.

Founded in 2004, Uranium International Corp. is an international resource exploration company. The Company's focus is on the acquisition and exploration of uranium properties. They are positioned to become a viable producer of uranium. Uranium International Corp. trades on the OTC Bulletin Board. They have their operations’ headquarters in Lone Tree, Colorado.

The Company's acquisitions consist of several groups of properties and are being transacted between Uranium International Corp., and Trans Atlantic Metals AB (a Swiss company) and Geoforum (a Swedish Company) and between Uranium International Corp. and Continental Precious Minerals (a Canadian company with mineral interests in Sweden). These properties and the associated licenses, represent their portfolio.  Uranium International intends to validate this portfolio through exploration, and expand it as warranted.

Uranium International Corp. acquired their current core group of properties, and their historic data concerning exploration and drilling, in 2008 and early 2009. In total, the Company now has agreements in place to explore an accumulated total uranium portfolio of just over 20.5 million resource pounds, which is technically compliant per National Instrument 43-101.

The Company entered a Letter Agreement to purchase thirteen exploration licenses uranium deposits held by Continental Precious Minerals Ltd. in Sweden, in April 2009. In January 2009, Uranium International entered into an agreement with Trans Atlantic Metals AB and its wholly owned subsidiary, T.A. Metals for exclusive options to acquire up to an 80 percent undivided interest in four mineral properties in Sweden. This is subject to a 3 percent NSR royalty. A similar transaction was negotiated with Geoforum on an additional four properties.

Uranium International Corp. has been focusing all of their efforts on moving their properties into a work program in Sweden. This country has been increasingly amenable to resource mining. Sweden provides a positive outlook on its uranium mining industry.

On April 5, 2010, Uranium International announced that they acquired an option on Colombian Claims from Mercer Gold Corporation. Yesterday, Uranium International Corp. announced that they entered into a Definitive Option Agreement to acquire the Guayabales Claims from Mercer Gold Corporation. Guayabales is a highly prospective gold and silver property located in Marmato, Caldas, Colombia. The property has been described thoroughly in a NI 43-101 compliant assessment report dated April 5, 2007.  In 2008, the previous Property optionor completed 17 holes totaling 2000 meters of drilling and 1980 samples.  Uranium International plans to evaluate the Property and will develop a work program in due course.

Today Uranium International Corp. announced that, effective after the close on April 14, 2010, the Company completed a non-brokered private placement financing. It involved the sale of an aggregate of 4,100,000 units of the Company, at a subscription price of $0.50 per Unit, for gross proceeds of $2,050,000. The net proceeds from the Financing will be used to fund Uranium International's initial obligations under their recently announced and definitive option agreement with Mercer Gold Corporation.

Uranium International Corp. (URNI) closed today's session at $0.95 up 15.85 percent. Volume was 90,000.

Procera Networks, Inc. (PKT)

Stock Stars, MicroCap Gems, OTC Journal, The Street, OTC Picks, and Small Cap Network reported on Procera Networks, Inc. (PKT), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Procera Networks Inc. delivers Evolved DPI solutions. These solutions give service providers awareness, control and protection of their applications and networks. The Company's main product suite, the PacketLogic line of platforms, leverages their advanced identification engine, DRDL™ (Datastream Recognition Definition Language). This is to provide accurate identification of network traffic in real-time. Procera Networks, Inc. trades on the NYSE Amex and they have their headquarters in Los Gatos, California.

PacketLogic has undergone deployment at more than 600 broadband service providers, telcos, governments and higher education campuses globally. PacketLogic products, as fully integrated solutions, give network managers access to relevant network traffic intelligence. This enables network optimization, creation of services (with the most accurate user and location awareness) and protection against malicious behavior.

PacketLogic is a deep packet inspection (DPI) solution. It offers broad feature-richness in the software modules LiveView, Filtering, Traffic Shaping, Statistics and WebStatistics. The PacketLogic hardware platforms offer a range of configurations from the entry-level 4 Mbps PL5600 through 2 Gbps PL7720.

The mid-range PL8720 is a 2RU unit with up to 10Gbps throughput. At the top of the line is the high-end PL10000 series. It has capacity up to 80Gbps and 5M subscribers per system. It consists of a modular AdvancedTCA (ATCA) chassis solution in two sizes – PL10005 5RU and PL10014 12RU.

PacketLogic Subscriber Manager (PSM) integrates PacketLogic with network systems. These include AAA, OSS, BSS, provisioning and policy managers. This enables per-user tracking and policies (user awareness), and knowledge of where in the network the user connects (location awareness).

On April 6, 2010, Procera Networks Inc. announced the industry's first purpose-built, two rack unit (2RU) 10 Gbps deep packet inspection (DPI) appliance. This is the PacketLogic PL8720. It has up to 10 Gbps of throughput in a cost and space efficient two rack unit form factor. The design of PacketLogic PL8720 is for customers with accelerating network growth plans who are transitioning or will transition from GE (gigabit Ethernet) to 10GE links. The PL8720 has the greatest DPI port density per rack unit on the market. It has up to eight 10GE or sixteen GE ports in a single appliance.

On Monday of this week, Procera Networks Inc. announced the appointment of Benjamin Teh to lead their Asia-Pacific (APAC) team as VP of Sales.

"Ben is an experienced sales executive with proven results and he brings excellent relationships with customers and partners in this key region," said James F. Brear, President and CEO of Procera Networks. "Security and computer networks technology are at the core of his experience.

Procera Networks, Inc. (PKT) closed Thursday's trading at $0.5488 up 6.56 percent. Volume was 795,383.

Intellipharmaceutics International Inc. (IPCI)

Recently, OTC Picks reported on Intellipharmaceutics International Inc. (IPCI), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of controlled and targeted novel oral solid drugs. Their patented Hypermatrix™ technology is a unique and validated multidimensional controlled-release drug delivery platform. It can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Intellipharmaceutics International Inc. trades on the NASDAQ Capital Market and they have their headquarters in Toronto, Ontario.

The Company's proprietary Hypermatrix™ technology is at the core of their controlled-release drug delivery approach. Controlled-release means releasing a drug into the bloodstream or at a target site in the body, over an extended period of time or at predetermined times. The flexibility of their Hypermatrix™ technology allows for the intelligent and efficient design of drugs. This is through the precise control of a number of key variables. In this way, the Company can respond to varying drug attributes and patient requirements, producing a desired controlled-release effect in a time and cost-effective manner.

Intellipharmaceutics is applying their technology to the development of both existing and new pharmaceuticals across a range of therapeutic classes. The Company is focusing their development activities in two niche markets. One is Difficult-to-produce controlled-release generic drugs (ANDA regulatory path). The second is Improved current therapies through controlled release (NDA regulatory path).

On April 13, 2010, Intellipharmaceutics International Inc. reported the results of operations for the three-month period ended February 28, 2010. Comparative information is that of the predecessor company Intellipharmaceutics Ltd. The loss for the three-month period ended February 28, 2010 was $1.4 million, or $0.13 per common share, compared with a loss of $0.6 million, or $0.06 per common share for the three-month period ended March 31, 2009.

The increased period-over-period loss is primarily due to increases in both research and development expenses and increases in selling, general and administrative expenses. The Company increased research and development expenditures due to a stronger financial position during the three-month period ended February 28, 2010 in comparison to the three-month period ended March 31, 2009.

Intellipharmaceutics International Inc. (IPCI) closed Thursday's trading session at $2.25 up 6.13 percent. Volume was 7,967.

Ezenia! Inc. (EZEN)

Today we are highlighting Ezenia! Inc. (EZEN) here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board Ezenia! Inc. is a leading provider of real-time collaboration solutions. The Company brings new and valuable levels of interaction and collaboration to corporate networks and eGovernment. Through integrating voice, video and data collaboration, their products enable groups to interact through a natural meeting experience. This is regardless of geographic distance. Founded in 1991, Ezenia! Inc. has their headquarters in Nashua, New Hampshire.

Ezenia! works to bring companies together in a natural forum: voice-to-voice, face-to-face, in real-time, across popular network standards.  Their products allow dispersed groups to work together in real-time. They can do this using capabilities such as instant messaging, white boarding, screen sharing and text chat. The Company also provides technical support and services to their resellers and direct customers.

Ezenia! Inc. has provided the InfoWorkSpace (IWS) collaboration solution to all segments of the global information sharing community for nearly a decade.  IWS is a productivity and value-added enterprise application tool.  It is content independent, which allows users in multiple industries and agencies to deploy successfully a wide spectrum of information sharing solutions to address their virtual team needs. IWS is well suited to applications in Healthcare, Education, Government, Defense and Commercial environments.

On Wednesday, April 14, 2010, Ezenia! Inc. announced that they received multiple awards from the Air Force. This amounts to approximately $800,000 of bookings, for the training of Air Force personnel on the Ezenia flagship product, InfoWorkSpace. These bookings are also for the field engineering services in assisting the Air Force in exercise preparation, on-site support, situation analysis, installation expertise, and engineering consultancy. 

Ezenia has received two awards so far for training services and one multi-year award for engineering support. The award for engineering support has the capability to expand up to fifty percent larger than its original commitment of 1500 hours.

Ezenia! Inc. (EZEN) closed Thursday's trading session at $0.16 up 45.45 percent. Volume was 158,023.

Baltia Air Lines Inc. (BLTA)

HotOTC.com, Cool Penny Stocks, StockEgg.com, Penny Invest, TheOTCBBList.com, and Stock Rich reported on Baltia Air Lines Inc. (BLTA), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Baltia Air Lines, Inc. is a New York corporation with their base of operations in Terminal 4 at JFK International Airport in New York. Baltia Air Lines Inc. is a United States startup airline company. No ticket sales are currently available through the Company. The Company's service is subject to receipt of government operating authority. Trading on the OTC Bulletin Board, Baltia Air Lines Inc. has their corporate headquarters in Rego Park, New York.

Baltia Air Lines is the only new start-up United States Part 121 (heavy jet operator) airline in existence that has received Department of Transportation approval, after JetBlue and Virgin America. Baltia's goal is to become the leading U.S. airline in the trans-Atlantic market. Their goal is to be the leading U.S. airline between the major U.S. cities and capital cities of Eastern Europe, including Russia, Latvia, Ukraine, and Belarus.

The Company intention is to provide high quality three-class passenger service, and reliable cargo and mail transportation. They plan to begin their foreign scheduled air transportation as the only U.S. airline, connecting directly New York and St. Petersburg.

On December 1, 2009, Baltia Air Lines, Inc. announced that they filed with the FAA to register the Company's first B747 aircraft. They filed it under Baltia Air Lines with registration number N705BL. This is one of five "N" numbers reserved for Baltia containing letters BL.

On March 2, 2010, the Company announced that they entered into a fuel agreement with SOVEX. This is for the purchase and delivery of jet fuel at Pulkovo airport in St. Petersburg. Subsequently, on March 25, Baltia Air Lines announced that they executed a cargo handling agreement. This is with Cargo Terminal Pulkovo for the physical handling of outbound and inbound cargo, ramp services, mail handling and shipping document processing.  The Pulkovo Cargo Terminal is the largest facility of its kind serving air cargo flows in northwestern Russia.   

On April 13, 2010, Baltia Air Lines, Inc. announced that they executed a lease agreement for office space at Pulkovo Airport.  Executive Vice President of Baltia Air Lines, Russell Thal stated, "The signing of the lease agreement in addition to our recently signed fuel and cargo agreements in St. Petersburg were made in preparation for the start of scheduled service. Station readiness is part of our certification requirements."

Baltia Air Lines Inc. (BLTA) closed Thursday's session at $0.07 down 6.67 percent. Volume was 36,000.

The QualityStocks Company Corner

Micro Identification Technologies Inc. (MMTC)

The QualityStocks Daily Newsletter would like to spotlight Micro Identification Technologies Inc. (MMTC) Today Micro Identification Technologies Inc. closed trading at $0.0450, which was up 21.62 percent from yesterday's close. Their volume today was 276,000 shares.

Micro Identification Technologies Inc. (MMTC) announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards.

Micro Identification Technologies Inc. (MMTC) is focused on becoming a global leader in developing, supporting and marketing rapid systems and processes that detect and identify microbial organisms. For several years the company has been working on the development of a breakthrough, laser-based microbial identification technology. This technology has been designed to be extremely fast and easy to use while not relying on conventional chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis.

The system works by measuring scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. By measuring scattered light at specific angles, MIT’s system detects and differentiates objects the size of bacteria, protozoa, yeasts and molds.

The company’s technology offers significant advantages over today’s methods of microbial detection, including lower cost, rapid results, easier use and the ability to test for multiple bacteria in one process. The system is statistically based and includes a unique MIT Microbe Library of pre-measured light scattering identifiers - or fingerprints - derived from the measurements of tens of thousands of individual microbes for each species and subspecies to be detected.

MIT’s technology has the potential to revolutionize the $5 billion rapid microbial test market by annually saving thousands of lives and tens of millions of dollars. Since 1998, the industry has had an annual expansion of 9.2 percent - with growth projections for 30 percent annually. MIT is well positioned with its cutting-edge microbial technology as demand continues to soar as a result of major health, safety and homeland security issues. Disclaimer

Micro Identification Technologies Inc. Blog

Micro Identification Technologies Inc. News:

Micro Identification Technologies, Inc. (MMTC) to be Featured in Small Cap Stock Newsletter QualityStocks Daily

Micro Identification Technologies Concludes a $500,000 Equity Based Private Placement

HealthNewsDigest.com Showcases Micro Identification Technologies: 'Shining a Light on Food-Borne Illnesses'

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB) Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.0115, which was up 4.55 percent from yesterday's close. Their volume today was 144,140 shares.

Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. (KBLB) is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Blog

Kraig Biocraft Laboratories Inc. News:

The New Age of Partnerships

Kraig Biocraft Laboratories, Inc. Greatly Exceeds Its Performance Goals

SectorWatch.biz: Paving the Way for Spider Silk

TapImmune, Inc. (TPIV)

The QualityStocks Daily Newsletter would like to spotlight TapImmune, Inc. (TPIV) Today, TapImmune, Inc. closed trading at $0.27, which was up 8.00 percent. Their volume today was 79,493 shares.

TapImmune, Inc. (TPIV) is a biotechnology company focused on developing innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product, the TAP vaccine, is a key componesnt of a mechanism that moves characteristic markers called antigens to the surfaces of cells. Without TAP, there is a large reduction in presentation of cancer markers, making it impossible for the immune system to spot rogue cells and cancerous cells, allowing them to grow undetected.

The company’s vaccine has demonstrated its effectiveness in restoring TAP which in-turn restores and augments the characteristic marker (antigen) and subsequent recognition and killing of cancer cells by the immune system. The TAP molecule also works to enhance targeted vaccines against infectious diseases. For example, including TAP in the studied Smallpox Vaccine showed potency was increased by 100-1,000 times.

TapImmune, Inc. (TPIV) technologies have broad applications in developing therapeutic and preventative vaccines. The company’s technologies have been featured on ABC News BusinessNow, B-TV, in BusinessWeek, Popular Mechanics and local news papers as well as many respected medical journals including the Journal of Immunology, Nature (Biotechnology), International Journal of Cancer, Cancer Research and PLoS Pathogens, among others.

Management believes that its cancer vaccine strategy is a unique therapeutic approach that addresses the problem of poor immune responses to cancer. Since restoring the TAP protein directs the body’s immune system to specifically target cancerous cells without damaging healthy tissue, this therapy potentially has a strong competitive advantage over other cancer therapies. Disclaimer

TapImmune Blog

TapImmune, Inc. News:

TapImmune Provides Shareholder Letter

TapImmune Inc. Signs R&D Collaboration Letter of Intent Agreement With Aeras Global TB Vaccine Foundation

TapImmune, Inc. Retains Wolfe Axelrod Weinberger Associates LLC as Its Investor Relations Counsel

National Automation Services, Inc. (NASV) 

The QualityStocks Daily Newsletter would like to spotlight National Automation Services, Inc. (NASV). Today National Automation Services, Inc. closed trading at $0.14, which was up 3.70 percent. Their volume today was 67,198 shares.  

National Automation Services, Inc. (NASV) announced they have obtained an equity financing commitment of $5 Million from Ascendiant Capital Group, LLC, a private equity firm, and its affiliate, Ascendiant Equity Partners, LLC.

National Automation Services, Inc. (NASV) is a public holding company focused on designing, engineering, installing and maintaining automated control systems for such business applications as waste water treatment, water treatment, airport security, bottling plants, power plants, metals, mining, breweries, food processing, tire making, textiles, plastics and nearly all production activities.  

Dominant players in the $500 Billion national and international automation controls market include Siemens, Honeywell, Fisher Controls, Johnson Controls and others. In addition to the multi-nationals, it has been estimated that there could be as many as 300 local and regional firms providing automation control services. In general, these companies have an edge on the larger behemoths because they can better respond to the needs of local business and municipalities.  

Unfortunately, for these smaller companies, they compete in a limited market space, have stunted growth prospects and have no way of monetizing their asset value. NAS aims to capitalize on this condition by acquiring and integrating the strongest local and regional players into a new organization that would allow for the synergies and efficiencies of a national company while keeping the competitive advantages of decentralized management and service.  

Of the 300 local and regional automation companies, 42 meet the company’s acquisition criteria; 11 of which have been targeted for acquisition over the next two years. NAS projects year-end 2010 revenues of more than $47 Million and year-end 2011 revenues of over $140 Million predicated on meeting its targeted acquisition schedule. With a solid business plan in place, NAS has a firm foundation to generate strong cash flow and increase shareholder value over the long-term. Disclaimer

National Automotion Services, Inc. Blog

National Automation Services, Inc. News:

National Automation Services, Inc. Secures Equity Financing Commitment for $5 Million

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

CitySide Tickets, Inc. (CIST) to Form CitySide Entertainment to Focus on Mixed Martial Arts Segment

CitySide Tickets, Inc., the national ticket shop that got its start outside Fenway Park in Boston, has grown determinedly and strategically from its humble roots to become a major contender in the event ticket market, offering tickets for just about any event out there from sports to theatre and music. The company recently announced a planned move to capitalize on the huge success of Mixed Martial Arts (MMA) with the formation of CitySide Entertainment – which will focus on promoting and sponsoring the rapidly growing and unique sport.

MMA draws a young, active demographic with a sizeable chunk of 18-24 olds, especially men, with the unique combination of mixed martial arts disciplines and raw, real full-contact fighting. The sport also draws the affluent as detailed in a recent report by Scarborough Sports Marketing which states the sports fans are 15% more likely to have $75k+ household income and 10% more likely to own a second home.

Although like CIST, MMA has humble roots, it has quickly grown into a multimillion-dollar mainstream sport with a footprint covering training halls throughout the US and abroad as well as pay-per-view and events. MMA is poised to become one of the most stable and profitable operating areas for ticket vendors like CIST.

CitySide CEO Michael DeAmicis confirmed the status of MMA as being “one of the fastest growing sports in the United States” and simply put that it was a natural move for the Company, which wants to become a major player in event ticket market. CitySide Tickets aims to make MMA a big part of their overall growth strategy, leveraging “the rapid growth within the MMA” to expand its own reach and influence.

CitySide Tickets is based in Boston with a store front but also vends tickets via their e-commerce site CitySideTickets.com and toll-free number (1-800-ANY-SEAT) for all kinds of events, no matter what your preference, including:

• Sports: MLB Baseball; NBA Basketball; NFL Football; NHL Hockey; Monster Jam; US Open Tennis Championship; WWE- World Wrestling Entertainment; National Finals Rodeo; and UFC Ultimate Fighting Championship.
• Concerts: Taylor Swift; Bon Jovi; Lady Gaga; Elton John; Billy Joel; and many more too numerous to list.
• Theatre: Wicked, The Jersey Boys, South Pacific, and Phantom of the Opera, to name a few.
• Racing: Daytona 500 at Daytona International Speedway and at Atlanta Motor Speedway; Darlington Raceway; Indianapolis Motor Speedway; Michigan International Speedway; Pocono Raceway and Watkins Glen International.

eDoorways Corp (EDWY) Eyes the iPad

eDoorways Corp. announced in its April 9th shareholder conference call that the company is already working on its first iPad app. The company’s CEO, Gary Kimmons, went further, indicating that, when finished, the new app could be different from anything they’ve done before.

eDoorways, known for its ongoing development of an innovative online platform to link business and consumers, is hot on the trail of Apple’s new iPad, seeing it as mirroring eDoorways’ vision of future consumer computing. In anticipation of this growing move toward a more elegant user interface, such as advanced touch-screen technology, eDoorways is designing its entire ecosystem with such devices in mind. The native eDoorways platform is similar to an expanded app, offering simplicity of use and rich information displayed in a concise space. Users can easily navigate the content-rich site, from initial query to final real-time connectivity with people, businesses, and solutions.

Other eDoorways platform features include the interactive expandable display of conversations, which lets users toggle between chats and quickly view new notifications. The same accordion style is used to display people and businesses that are suggested by the search engine, pointing the user to the most relevant connections.

eDoorways’ intuitive and concise user interface is one of the many qualities that is aimed at maximizing the latest computing technologies, such as the Apple iPad. In addition, eDoorways sees iPad as offering support to its integration of the company’s SOLVE and LEARN doorways, due to its inherent mixing of information resources and types. The iPad was recently called “a revolution in mashing up text, video, course materials, [and] student input” by Duke University’s Tracy Futhey. Such mixing reflects eDoorways view of the future, one of cloud computing and flexible collaboration, a perfect fit for iPad and for eDoorways.

eDoorways CEO Kimmons summed it up, saying that the iPad may prove to be the perfect peripheral device to showcase eDoorways’ intelligent performance support capabilities.

China Sun Group (CSGH) Posts Q3 2010 Results, Future Outlook

China Sun Group High-Tech Co. Ltd. produces cobalt-based raw materials for rechargeable Lithium-ion (Li) batteries in China. The company today announced its financial results for the third quarter ended February 28, 2010, and its business outlook for the upcoming years.

The company reported third-quarter revenues at $10.8 million, up 22.7 percent from $8.8 million for the third quarter of 2009, an increase attributable mainly due to sales of the company’s newly launched LIP product, which accounted for about 19.7 percent of total sales in the quarter.

Gross profit was $3.4 million, up 42 percent compared to $3.2 million for the three months ended February 28, 2009. Gross margin was 31.3 percent compared to 36.9 percent in the same quarter of last year. The company attributes the decrease in gross margin primarily to a decrease in the market price for cobalt. China Sun Group said it expects gross margins to recover in the fourth quarter of fiscal 2010. Net income was $2.2 million in third quarter, or $0.04 per fully diluted share, compared to net income of $2.0 million, or $0.04 per fully diluted share, during the same period of 2009.

“In the third quarter of fiscal year 2010, selling prices of our cobalt oxide product declined in tandem with the falling cobalt prices. Our cobalt inventory was purchased in advance of the drop in cobalt prices, which impacted gross margin. While some domestic competitors turned unprofitable due to this factor, we were able to maintain profitability due to higher yields and better capacity utilization,” Bin Wang, chairman of China Sun Group stated in the press release.

The company anticipates its new LIP product to positively impact future revenues as it secures its foothold in the clean energy industry.
“We also launched our LIP product, which is expected to become an important revenue contributor in our future business operations. The urgent need to develop low emission vehicles to reduce air pollution in China has and will continue create huge demand for clean energy and related products. Our LIP product is a core material of lithium power batteries for zero emission automobiles. As one of the few major LIP manufacturers in China, we believe we are well positioned to achieve rapid and profitable growth over the time,” Wang stated in the press release. For the quarter ended May 31, 2010, China Sun Group said it anticipates to generate approximately $11.0 million to $12.0 million in revenue and $2.0 million to $2.5 million in net income. The outlook is supported by the company’s plans for all around improvement.

“Having been a leader in the cobalt oxide manufacturing industry for years, China Sun Group has recently expanded our business to the more advanced and profitable LIP segment. We will strategically increase our productivity and research efforts of LIP over the next few years to achieve long term sustainable growth for our shareholders. We will also significantly improve our corporate governance and communications with the investment community going forward and look forward to listing our shares on a senior stock exchange soon,” Wang stated.

North American Palladium Ltd. (PAL) Restarts Palladium Production

North American Palladium Ltd. is a Canadian precious metals company focused on the production of palladium and gold. The company’s flagship mine, the Lac des Iles (LDI), is one of North America’s two primary palladium producers. The company announced yesterday that it has restarted palladium production at this mine.

On an annualized basis, North American Palladium expects to produce 140,000 ounces of palladium per year. The company’s president and CEO, William J. Biggar, said, “As Canada’s only primary palladium producer, we are extremely pleased to be back in operation and generating cash flow at LDI. The restart is well timed to capitalize on the recent increase in the price of palladium, which now exceeds $250 per ounce.” Prices have risen recently due to increased vehicle sales globally, led by increases in emerging markets such as China.

Ore production from the Roby Underground zone at the LDI mine is currently about 2,000 tons per day and is expected to increase to its target rate of 2,600 tons per day by May 1. The company also announced the renewal of its smelting contract with Xstrata Nickel, a subsidiary of the global mining giant Xstrata. The terms of the contract are believed to be similar to the previous contract. A new feature to the contract does entitle the company to receive advance payments of 70 percent within 60 days following the month of concentrate delivery.

North American Palladium’s CEO added, “We…look forward to a productive year ahead. With two operating mines and a number of development projects in our portfolio, North American Palladium is well positioned to grow its production profile.”


Sponsors of the Day


The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) to be Featured in Small Cap Stock Newsletter QualityStocks Daily



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336